|  | Taking the Fight to Rare Cancers Beating rare cancers demands expertise in oncology and rare diseases. Our white paper shows how adaptive design, study committees, and cross-industry cooperation are fueling real progress. Premier Research. Built for Biotech℠ |
Today's Rundown Featured Story | | | Friday, October 11, 2019 Five Prime Therapeutics’ interim CEO William Ringo has moved to lay off 70 employees within weeks of taking up the position. The cuts will leave Five Prime with a “small research group” focused on taking clinical candidates forward with the help of service providers and contractors. |
|
|---|
|
Top Stories Friday, October 11, 2019 Gilead and Galapagos have said that 52-week phase 3 data for JAK1 inhibitor filgotinib in rheumatoid arthritis are consistent with earlier readouts. The update comes as Gilead prepares to make the case that filgotinib is safe and effective to the FDA. Friday, October 11, 2019 Micro cap anti-infective biotech Aridis Pharmaceuticals has gained a new chief medical officer in the form of former Takeda Vaccines exec Paul Mendelman, M.D. Monday, October 7, 2019 A clinical trial is a measurement system, but too often, we fail to calibrate the most significant of measurement instruments: trial participants. Friday, October 11, 2019 Shionogi and Hsiri Therapeutics joined forces last year in a licensing and R&D deal focused on tuberculosis and non-tuberculous lung infections. Now, they are expanding that deal, with the Japanese biotech licensing a new technology from Hsiri that will be “complementary to Shionogi's current research” in the collaboration. Thursday, October 10, 2019 Stem cells can save lives for patients with blood cancer, but hurdles remain to effectively harvest them for transplantation. Scientists at the University of California, Santa Cruz found Pfizer’s erectile dysfunction drug Viagra facilitates the release of stem cells from the bone marrow into the bloodstream, which could ease collection. Thursday, October 10, 2019 In this week's EuroBiotech Report, UCB inks $2.5 billion Ra takeout, MiroBio raises £27 million and Bayer forms Riken drug discovery pact. Friday, October 11, 2019 Indian drugmakers Aurobindo and Glenmark are cited by the FDA again. Takeda inks IBD drug target discovery pact with Prometheus. Chinese biotech Ascletis lures Novartis veteran as CSO after losing short-termed CMO to his old employer MSD China. And more. Friday, October 11, 2019 Gilead nabs ex-Genentech exec Parsey as CMO; Shire CEO Ornskov to take over at Galderma; longtime BIO CEO Greenwood will step down after 2020 election. Resources Sponsored by: Medidata Simplified filing, improved oversight, audit readiness: is your eTMF system delivering best-in-class benefits? Sponsored by: Colorcon® Learn about how you better manage product authentication and battle drug counterfeiting with innovative solutions. Sponsored by: Cortellis, a Clarivate Analytics Solution Download this report for full details of Life sciences M&As in the second quarter of 2019 with notes and trends. Sponsored by: Elligo Health Research Find out how it leverages real-world data and novel IntElligo Research Stack™ technology to help researchers battle rising costs, cumbersome processes, and stagnant participation — bridging the gap between research and care. Sponsored by: InformedDNA Download this complimentary guide paper that explores key strategies for a successful genetics-informed clinical trial. Sponsored by: Life Image The time has finally come when medical imaging can be effectively utilized into the RWE process. Read the whitepaper on the best practices for incorporating Real World Imaging.™ Sponsored by: Patheon, by Thermo Fisher Scientific Is your API development on track? Sponsored by: BioAnalytix, Inc. Download the White Paper and learn how detailed characterization can guide successful development of gene therapy products. Sponsored by: ON24 Compare digital program performance and audience engagement among your life sciences peers. Sponsored by: Decision Resources Group Clinically Integrated Networks are vehicles for powerful IDNs to extend their influence into the physician sector and play a key role for IDNs trying to pave a path to becoming a self-contained healthcare ecosystem. Sponsored by: Reprints Desk, Inc. Slashing your R&D costs is easier than you think. Sponsored by: Roche and IQVIA A global landscape study of funding trends and innovations. Sponsored by: Blue Matter, strategic consultants in the life sciences White paper providing an overview of precision medicine in oncology, as well as a look ahead at future developments and keys to success for pharmaceutical and diagnostics companies. Sponsored by: Outer Edge Technology Find out how outsourcing your IT requirements enhances the bottom line while creating strategic advantage. Sponsored by: Vineti Developing a cell therapy, gene therapy, or personalized cancer vaccine? Modern data management makes a critical difference in operational and regulatory outcomes. This whitepaper will help your team leverage the latest data strategies for success. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. | 
